VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Historical Holders from Q1 2023 to Q3 2025

Symbol
VYNE on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
18.5M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
3.92M
Holdings value
$1.32M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
31
Number of buys
14
Number of sells
-26
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CITADEL ADVISORS LLC 0% -103% $1.25K -$367K 3.73K -99.7% Kenneth Griffin 30 Sep 2025

Institutional Holders of VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3.92M $1.32M -$9.03M $0.34 31
2025 Q2 8.05M $13.3M +$1.5M $1.65 44
2025 Q1 7.11M $11.4M -$2.38M $1.58 36
2024 Q4 7.03M $23.3M +$606K $3.35 34
2024 Q3 7.31M $14.3M -$1.23M $1.88 31
2024 Q2 7.94M $16M +$243K $1.97 30
2024 Q1 6.41M $19.7M +$378K $3.07 29
2023 Q4 7.86M $18.3M +$17.2M $2.33 32
2023 Q3 360K $1.45M -$33.7K $4.04 20
2023 Q2 376K $1.53M +$198K $4.10 19
2023 Q1 335K $1.03M +$1.03M $3.08 19